Genetically engineered lymphocytes in metastatic melanoma: TIL 1383I TCR transduced T-cells are detectable after infusion
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Genetically engineered lymphocytes in metastatic melanoma: TIL 1383I TCR transduced T-cells are detectable after infusion ; volume:1 ; number:1 ; day:7 ; month:11 ; year:2013 ; pages:1 ; date:11.2013
Journal for ImmunoTherapy of Cancer ; 1, Heft 1 (7.11.2013), 1, 11.2013
- Urheber
-
Regan, Courtney
- Beteiligte Personen und Organisationen
-
Nishimura, Michael
Clark, Ann Lau
Moxley, Kelly
Scurti, Gina
Slepushkin, Vladimir
Roy, André
Schonely, Kathy
Dropulic, Boro
Clark, Joseph
SpringerLink (Online service)
- DOI
-
10.1186/2051-1426-1-S1-P31
- URN
-
urn:nbn:de:1111-2016072655553
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Regan, Courtney
- Nishimura, Michael
- Clark, Ann Lau
- Moxley, Kelly
- Scurti, Gina
- Slepushkin, Vladimir
- Roy, André
- Schonely, Kathy
- Dropulic, Boro
- Clark, Joseph
- SpringerLink (Online service)
Ähnliche Objekte (12)
TCR-repertoire and homeostasis of Foxp3* regulatory T-cells
Development of a novel TCR avidity assay for human CD8+ T-cells
Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes
Deciphering TCR signaling in metabolically activated T-cells in NASH and liver cancer development
Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modules
Avidity characterization of genetically engineered T-cells with novel and established approaches
Recognition of renal cell carcinoma by CD8+ and CD4+ TCR-engineered T lymphocytes
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction
TcR
Effects of desialyation on TCR-cross-linking and antigen sensitivity of CD8 positive T lymphocytes
Globally shared TCR repertoires within the tumor-infiltrating lymphocytes of patients with metastatic gynecologic cancer
P71. Adoptive transfer of TCR gene-transduced lymphocytes targeting MAGE-A4 for refractory esophageal cancer
TCR-repertoire and homeostasis of Foxp3* regulatory T-cells
Development of a novel TCR avidity assay for human CD8+ T-cells
Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes
Deciphering TCR signaling in metabolically activated T-cells in NASH and liver cancer development
Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modules
Avidity characterization of genetically engineered T-cells with novel and established approaches
Recognition of renal cell carcinoma by CD8+ and CD4+ TCR-engineered T lymphocytes
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction
TcR
Effects of desialyation on TCR-cross-linking and antigen sensitivity of CD8 positive T lymphocytes
Globally shared TCR repertoires within the tumor-infiltrating lymphocytes of patients with metastatic gynecologic cancer
P71. Adoptive transfer of TCR gene-transduced lymphocytes targeting MAGE-A4 for refractory esophageal cancer
TCR-repertoire and homeostasis of Foxp3* regulatory T-cells
Development of a novel TCR avidity assay for human CD8+ T-cells
Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes
Deciphering TCR signaling in metabolically activated T-cells in NASH and liver cancer development
Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modules
Avidity characterization of genetically engineered T-cells with novel and established approaches
Recognition of renal cell carcinoma by CD8+ and CD4+ TCR-engineered T lymphocytes
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction
TcR
Effects of desialyation on TCR-cross-linking and antigen sensitivity of CD8 positive T lymphocytes
Globally shared TCR repertoires within the tumor-infiltrating lymphocytes of patients with metastatic gynecologic cancer